Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Part of paid clinical trials in Orlando, Florida.

Sponsor
AdventHealth
Study ID
NCT07231159
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • referral for definitive diagnosis based on their cancer screening results — BEHAVIORAL
    Need for radiological diagnosis
  • Engagement — BEHAVIORAL
    Engage in stakeholder focus groups to provide feedback about program operations

Study Details

To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.

Key Dates

Start date
Nov 17, 2025
Status verified
Sep 2025
Primary completion
Aug 30, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: community-based initiative for screening, diagnosis, and treatment of breast, lung, and prostate
    Identify differences between adults who accept or decline cancer follow-up diagnosis and treatment, and clinical trial screening Identify barriers and facilitators to cancer screening, diagnosis, treatment, and clinical trial screening Understand perceptions towards navigators in the cancer care continuum
  • Arm: Recruitment of Stakeholder
    Investigators will establish relationships with community stakeholders, providers, and other key personnel to inform them of the program, the study, and opportunities to engage in stakeholder focus groups to provide feedback about program operations. For those interested in participating, a study team member will explain the study and the requirements for participation, review the informed consent form in detail, and obtain consent.

Primary Outcome Measure

The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance, [ Time Frame: From enrollment to the end of the 3 month follow-up for a total of 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
AdventhealthOrlandoFlorida32804-

Find similar trials in Orlando, FL

By condition
Breast cancerProstate cancer
By specialty
OncologyBreast oncologyWomen's healthProstate oncologyMen's healthUrology
By research site
Adventhealth· Orlando, FL

Related Studies